Aortic valve replacement with or without concomitant coronary artery bypass grafting in very elderly patients aged

Kazuyoshi Takagi1, Koichi Arinaga2, Tohru Takaseya2

  • 1Division of Cardiovascular Surgery, Department of Surgery, Kurume University School of Medicine, 67 Asahimachi, Kurume, 830-0011, Japan. takagi13@me.com.

Heart and Vessels
|May 13, 2020
PubMed

Insights

Aortic valve replacement (AVR) with or without coronary artery bypass grafting (CABG) is safe for patients 85 and older. Outcomes, including survival, were similar between groups, demonstrating acceptable early and long-term results.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Geriatric Medicine

Background:

  • Degenerative aortic stenosis is a prevalent condition in the aging population.
  • While less invasive options exist, open-heart surgery remains crucial for elderly patients with complex cardiac conditions.
  • Severe coronary artery disease often necessitates combined procedures during aortic valve replacement.

Purpose of the Study:

  • To analyze the outcomes of very elderly patients (≥85 years) undergoing aortic valve replacement (AVR).
  • To compare outcomes between isolated AVR and AVR combined with coronary artery bypass grafting (CABG) in this age group.

Main Methods:

  • Retrospective analysis of 29 patients aged ≥85 years undergoing AVR.
  • Patients were divided into two groups: AVR with CABG (Group AC, n=11) and isolated AVR (Group A, n=18).
  • Outcomes assessed included operative mortality, morbidity, length of stay, and long-term survival rates.

Main Results:

  • Aortic cross-clamp time was significantly longer in Group AC (126.5 min) compared to Group A (96.9 min).
  • Major morbidity rate was higher in Group AC (36%) versus Group A (6%).
  • No significant differences were observed in 30-day mortality, hospital mortality, ICU/hospital stay, or long-term survival rates between the groups.

Conclusions:

  • Aortic valve replacement with or without CABG can be safely performed in carefully selected very elderly patients.
  • The procedure offers acceptable early and long-term results for patients aged 85 and above.
  • Combined AVR and CABG demonstrates comparable outcomes to isolated AVR in terms of mortality and survival in this population.

Related Concept Videos

Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
273
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
171
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
330
Aortic Regurgitation IV: Nursing Management01:17

Aortic Regurgitation IV: Nursing Management

A nurse managing a patient with aortic regurgitation begins with a comprehensive assessment, including a review of the patient's medical history, family history, and lifestyle factors. During the cardiac examination, the nurse listens for heart sounds and checks for signs of valve abnormalities. The nurse also observes for symptoms such as dyspnea, orthopnea, and paroxysmal nocturnal dyspnea and assesses the patient's endurance and daily activity tolerance.Based on the findings, the nurse...
207
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
261
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
194